galvani.bio Report : Visit Site

Technical data of the galvani.bio

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host galvani.bio. Currently, hosted in United Kingdom and its service provider is Webfusion Internet Solutions .

the related websites

edenstrust.org.uk bbc.co.uk ftrspa.it resources.schoolscience.co.uk redstargrowers.co.uk powerup.ukpowernetworks.co.uk genome.ch.bbc.co.uk bolognaprocess2019.it ecglibrary.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.39 (Unix) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

about us our mission & values partnership our people careers contact about us is a new company, established in november 2016, dedicated to the development of bioelectronic medicines – a new class of medicines consisting of miniaturised, implantable devices. formed through a partnership between global healthcare company, gsk, and leading technology company, verily life sciences, combines the complementary expertise of its parent companies to enable the research, development and commercialisation of bioelectronic therapies. bioelectronic medicine is an emerging scientific field, aiming to use tiny implantable devices to change precise electrical signals in nerves to treat a range of debilitating chronic diseases. represents an important step change in the research and development of these medicines, combining gsk’s discovery and development expertise and deep understanding of disease biology with verily’s world leading expertise in the miniaturisation of low power electronics, device development, data analytics and software development for clinical applications. our mission & values at galvani, we believe bioelectronics have the potential to change the face of medical science forever… and our ambition is to take the lead. we are developing the expertise to place tiny devices inside the human body. these will be programmed to read and modify electrical signals passing along nerves in the body, to restore health. to realise this step change, we challenge our people to think the extraordinary, to be brave, and to forge unlikely alliances and partnerships. we embrace radical new thinking and believe that through this, we can shape the future of medical science. the partnership our partnerships makes us who we are. at we believe that when we work together, we can harness the power of mutual knowledge to change lives for the better. we recognise that bringing bioelectronic medicines to patients will depend on experts across a range of disciplines working together and sharing their knowledge and expertise. bioelectronics requires the combined skills of world-leading biologists, engineers, clinicians and technologists. so we’re partnering with a diverse range of experts to achieve our mission – as well as benefiting from our parent companies’ world class drug discovery and development and technological expertise. our people filters all a-c d-f g-i j-l m-o p-r s-u v-z adam roth vice president and head of business operations adam heads business operations for . in this capacity he leads a variety of functions including business development and transactions, alliance management, procurement, it, market insights, strategy, grants, communications, administration, and facilities. prior to the formation of galvani, adam led business development activities for the bioelectronics r&d; unit of glaxosmithkline (gsk). he joined gsk in 2010, working within r&d; strategy for the pharmaceutical r&d; organization. prior joining gsk, adam worked in the healthcare consulting practice of mckinsey & company and in finance within the semiconductor manufacturing division of the intel corporation. he holds a ph.d. in cellular and molecular biology, an mba specializing in finance & entrepreneurship, and a b.s. in engineering science and mechanics, concentrating in biomedical engineering. http://linkedin.com http://twitter.com alice bradney director, patents alice is responsible for intellectual property activities for . alice joined gsk in 2004 and has developed worldwide patent strategies for internationally-based research teams, managed worldwide outside counsel in patent prosecution and litigation matters and has advised r&d; and business development decision makers on patentability, freedom-to-operate issues, in-licensing opportunities and regulations governing development of nih funded technology. she has a bs in biological sciences, a phd in microbiology (immunology focus) and postdoctoral experience in hiv and immunology. she is a member of the north carolina state bar and a patent attorney registered to practice before the u.s. patent and trademark office. arun sridhar director and head of disease biology arun was a founding member of the gsk bioelectronics r&d; efforts and has been instrumental in establishing the disease biology portfolio. as director & head of disease biology, he currently oversees the academic collaborations in disease pathobiology and will ensure a sustainable biology pipeline for the future of . his strong integrative physiology and clinical cardiology experience provides an excellent bird’s eye view to initiate and test the impact of novel neural circuits for therapy. prior to bioelectronics, arun was a key contributor to cardiovascular safety screening strategies and was the first to set up stem cell cardiomyocyte based screening at gsk. he has extensive surgical experience, having performed adult and pediatric cardiac surgeries and translational research. billie-jo page senior team administrator billie-jo is a senior team administrator, and has over 10 years of experience working in hr, recruitment and executive support. she works closely with clare and lynsay to provide support to the team. prior to joining galvani in 2017, she worked for gsk and cisco systems in global hr roles while also handling multiple projects, energy/reward and resilience initiatives and hr support for employees, vendors and stakeholders. christopher lai director, business development & project management christopher lai, md, mba is a director in business development and project management for . his main role is to facilitate transactions and support the development of our assets to clinical development. prior to , christopher was with gsk for 3 years, working in worldwide business development and r&d; strategy development. prior to this role, he was in u.s. respiratory finance, supporting gsk’s respiratory launches of anoro, breo and nucala. before gsk, christopher was an emergency physician who practiced at several institutions such as kaiser, sutter and duke. he continues to practice at the durham va er. he obtained his business degree at duke university’s fuqua school of business in 2013, his medical degree at the ohio state university college of medicine in 2002 and trained in emergency medicine at the university of pittsburgh in 2005. prior to medical school, he spent nearly 2 sleepless years at citigroup in investment banking. clare de vere executive assistant clare de vere is executive assistant to kris famm, and provides administrative support to the team having joined the group in may 2015. clare previously worked with gsk in wwbd, biopharmaceuticals, respiratory and hr. dali wu investigator, surgical development & treatment discovery dali holds a surgical investigator role within surgical development & treatment discovery at . here he characterises the target nerves and develops novel surgical approaches and equipment for interfacing. previously dali was part of the bioelectronics r&d; unit at gsk working as surgical development scientist. dali is a neurosurgeon from taiwan and holds a phd in surgical sciences. during his academic research he found a functional connectivity between the sensory thalamus and the periaqueductal grey in pain modulation. daniel chew director, neural interfaces and in vivo science, neuromodulation devices daniel leads the neural interfacing development, and in vivo delivery efforts, at the stevenage site in the uk, and directs the laboratory work conducted there. the laboratory, drives early stage feasibility studies of autonomic nervous system neuromodulation, across a pipeline of disease indications. work centres around exploring the fundamentals of nerve physiology, and optimising ways to interact with the disparate anatomy. this involves the pursuit of ex vivo and in vivo electrophysiology methods, while driving the process of development of mechanically and electrically c

URL analysis for galvani.bio

https://www.galvani.bio/privacy-policy/
https://www.galvani.bio//#contact
https://www.galvani.bio/cookies/
http://www.galvani.bio/intern/
https://www.galvani.bio//#powerwithin
https://www.galvani.bio//tel:+44
(0)20
8047
5000
https://www.galvani.bio
https://www.galvani.bio//#news
https://www.galvani.bio//#newsletter
https://www.galvani.bio//#partnership
https://www.galvani.bio//#ourpeople
https://www.galvani.bio//#about
https://www.galvani.bio//mailto:[email protected]

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .